Regulation and role of p21-activated kinase 3 by corticotropin-releasing factor in mouse pituitary

Regulatory Peptides

Volumn 152, Issue 1-3, 2009, Pages 88-94

  Kageyama, Kazunori ^a   Sakihara, Satoru ^a   Suda, Toshihiro ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

Anterior pituitary; Corticotroph; Corticotropin releasing factor; Corticotropin releasing factor receptor; Glucocorticoids

Indexed keywords

BINDING PROTEIN; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR BINDING PROTEIN; DEXAMETHASONE; FURIN; GALANIN; GLUCOCORTICOID; MESSENGER RNA; P21 ACTIVATED KINASE 3; REGULATOR PROTEIN; TUBULIN; UNCLASSIFIED DRUG;

ACTH SECRETING CELL; ADENOHYPOPHYSIS; ADRENAL GLAND; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CELL VIABILITY; COLORIMETRY; CONTROLLED STUDY; DNA MICROARRAY; ENZYME REGULATION; GENE EXPRESSION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS PERIVENTRICULAR NUCLEUS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; STRESS;

ANIMALS; CELLS, CULTURED; CORTICOTROPIN-RELEASING HORMONE; FEMALE; GALANIN; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; P21-ACTIVATED KINASES; PITUITARY GLAND; PROPROTEIN CONVERTASE 1; RNA, MESSENGER; TUBULIN;

MUS;

EID: 57249089008     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2008.10.003     Document Type: Article

References (40)

1. Suda T., Kageyama K., Sakihara S., and Nigawara T. Physiological roles of urocortins, human homologues of fish urotensin 1, and their receptors. Peptides 25 (2004) 1689-1701
2. Vale W., Spiess J., Rivier C., and Rivier J. Characterization of a 41 residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 213 (1981) 1394-1397
3. Kageyama K., Hanada K., Iwasaki Y., Sakihara S., Nigawara T., Kasckow J., and Suda T. Pituitary adenylate cyclase-activating polypeptide stimulates corticotropin-releasing factor, vasopressin and interleukin-6 gene transcription in hypothalamic 4B cells. J Endocrinol 195 (2007) 199-211
4. Whitnall M.H. Regulation of the hypothalamic corticotropin-releasing hormone neurosecretory system. Prog Neurobiol 40 (1993) 573-629
5. Vale W., Vaughan J., and Perrin M.H. Corticotropin-releasing factor (CRF) family ligands and their receptors. Endocrinologist 7 (1997) 3S-9S
6. Chang C.P., Pearse II R.V., O'Connell S., and Rosenfeld M.G. Identification of a seven transmembrane helix receptor for corticotropin-releasing factor and sauvagine in mammalian brain. Neuron 11 (1993) 1187-1195
7. Chen R., Lewis K.A., Perrin M.H., and Vale W.W. Expression cloning of a human corticotropin-releasing-factor receptor. Proc Natl Acad Sci USA 90 (1993) 8967-8971
8. Vita N., Laurent P., Lefort S., Chalon P., Lelias J.M., Kaghad M., Le Fur G., Caput D., and Ferrara P. Primary structure and functional expression of mouse pituitary and human brain corticotrophin releasing factor receptors. FEBS Lett 335 (1993) 1-5
9. Kishimoto T., Pearse II R.V., Lin C.R., and Rosenfeld M.G. A sauvagine/corticotropin-releasing factor receptor expressed in heart and skeletal muscle. Proc Natl Acad Sci USA 92 (1995) 1108-1112
10. Lovenberg T.W., Liaw C.W., Grigoriadis D.E., Clevenger W., Chalmers D.T., De Souza E.B., and Oltersdorf T. Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc Natl Acad Sci USA 92 (1995) 836-840
11. Stenzel P., Kesterson R., Yeung W., Cone R.D., Rittenberg M.B., and Stenzel-Poore M.P. Identification of a novel murine receptor for corticotropin-releasing hormone expressed in the heart. Mol Endocrinol 9 (1995) 637-645
12. Kageyama K., Gaudriault G.E., Suda T., and Vale W.W. Regulation of corticotropin-releasing factor receptor type 2 beta mRNA via cyclic AMP pathway in A7r5 aortic smooth muscle cells. Cell Signal 15 (2003) 17-25
13. Pisarchik A., and Slominski A.T. Alternative splicing of CRH-R1 receptors in human and mouse skin: identification of new variants and their differential expression. FASEB J 15 (2001) 2754-2756
14. Lovenberg T.W., Chalmers D.T., Liu C., and De Souza E.B. CRF2 alpha and CRF2 beta receptor mRNAs are differentially distributed between the rat central nervous system and peripheral tissues. Endocrinology 136 (1995) 4139-4142
15. Perrin M.H., and Vale W.W. Corticotropin releasing factor receptors and their ligand family. Ann N Y Acad Sci 885 (1999) 312-328
16. Kageyama K., Gaudriault G.E., Bradbury M.J., and Vale W.W. Regulation of corticotropin-releasing factor receptor type 2 beta messenger ribonucleic acid in the rat cardiovascular system by urocortin, glucocorticoids, and cytokines. Endocrinology 141 (2000) 2285-2293
17. Manser E., Huang H.Y., Loo T.H., Chen X.Q., Dong J.M., Leung T., and Lim L. Expression of constitutively active alpha-PAK reveals effects of the kinase on actin and focal complexes. Mol Cell Biol 17 (1997) 1129-1143
18. Kasagi Y., Horiba N., Sakai K., Fukuda Y., and Suda T. Involvement of cAMP-response element binding protein in corticotropin-releasing factor (CRF)-induced down-regulation of CRF receptor 1 gene expression in rat anterior pituitary cells. J Neuroendocrinol 14 (1995) 587-592
19. Moriyama T., Kageyama K., Kasagi Y., Iwasaki Y., Nigawara T., Sakihara S., and Suda T. Differential regulation of corticotropin-releasing factor receptor type 1 (CRF1 receptor) mRNA via protein kinase A and mitogen-activated protein kinase pathways in rat anterior pituitary cells. Mol Cell Endocrinol 243 (2005) 74-79
20. Li H., Robinson P.J., Kawashima S., Funder J.W., and Liu J.P. Differential regulation of MAP kinase activity by corticotropin-releasing hormone in normal and neoplastic corticotropes. Int J Biochem Cell Biol 30 (1998) 1389-1401
21. Cibelli G., Corsi P., Diana G., Vitiello F., and Thiel G. Corticotropin-releasing factor triggers neurite outgrowth of a catecholaminergic immortalized neuron via cAMP and MAP kinase signalling pathways. Eur J Neurosci 13 (2001) 1339-1348
22. van Wijk P.A., van Neck J.W., Rijnberk A., Croughs R.J., and Mol J.A. Proliferation of the murine corticotropic tumour cell line AtT20 is affected by hypophysiotrophic hormones, growth factors and glucocorticoids. Mol Cell Endocrinol 111 (1995) 13-19
23. Muglia L.J., Jacobson L., Luedke C., Vogt S.K., Schaefer M.L., Dikkes P., Fukuda S., Sakai Y., Suda T., and Majzoub J.A. Corticotropin-releasing hormone links pituitary adrenocorticotropin gene expression and release during adrenal insufficiency. J Clin Invest 105 (2000) 1269-1277
24. Muglia L., Jacobson L., and Majzoub J.A. Production of corticotropin-releasing hormone-deficient mice by targeted mutation in embryonic stem cells. Proc Natl Acad Sci USA 780 (1996) 49-59
25. Fukuda Y., Kageyama K., Nigawara T., Kasagi Y., and Suda T. Effects of corticotropin-releasing hormone (CRH) on the synthesis and secretion of proopiomelanocortin-related peptides in the anterior pituitary: a study using CRH-deficient mice. Neurosci Lett 367 (2004) 201-204
26. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25 (2001) 402-408
27. Melzig M.F., Papsdorf G., Loose R., Winkler A., Beyermann M., Krause E., and Zipper J. Effects of long term treatment with corticotropin releasing factor on corticotropic tumor cells in vitro. Regul Pept 74 (1998) 35-40
28. Childs G.V., Rougeau D., and Unabia G. Corticotropin-releasing hormone and epidermal growth factor: mitogens for anterior pituitary corticotropes. Endocrinology 136 (1995) 1595-1602
29. Al-Gahtany M., Horvath E., and Kovacs K. Pituitary hyperplasia. Hormones (Athens) 2 (2003) 149-158
30. Zhang S., Han J., Sells M.A., Chernoff J., Knaus U.G., Ulevitch R.J., and Bokoch G.M. Rho family GTPases regulate p38 mitogen-activated protein kinase through the downstream mediator Pak1. J Biol Chem 270 (1995) 23934-23936
31. Balasenthil S., Sahin A.A., Barnes C.J., Wang R.A., Pestell R.G., Vadlamudi R.K., and Kumar R. p21-activated kinase-1 signaling mediates cyclin D1 expression in mammary epithelial and cancer cells. J Biol Chem 279 (2004) 1422-1428
32. McPhie D.L., Coopersmith R., Hines-Peralta A., Chen Y., Ivins K.J., Manly S.P., Kozlowski M.R., Neve K.A., and Neve R.L. DNA synthesis and neuronal apoptosis caused by familial Alzheimer disease mutants of the amyloid precursor protein are mediated by the p21 activated kinase PAK3. J Neurosci 23 (2003) 6914-6927
33. Knaus U.G., Morris S., Dong H.J., Chernoff J., and Bokoch G.M. Regulation of human leukocyte p21-activated kinases through G protein-coupled receptors. Science 269 (1995) 221-223
34. Westphal N.J., and Seasholtz A.F. CRH-BP: the regulation and function of a phylogenetically conserved binding protein. Front Biosci 11 (2006) 1878-1891
35. Potter E., Behan D.P., Fischer W.H., Linton E.A., Lowry P.J., Sawchenko P.E., and Vale W.W. The central distribution of a corticotropin-releasing factor (CRF)-binding protein predicts multiple sites and modes of interaction with CRF. Proc Natl Acad Sci USA 89 (1992) 4192-4196
36. Potter E., Behan D.P., Fischer W.H., Linton E.A., Lowry P.J., and Vale W.W. Cloning and characterization of the cDNAs for human and rat corticotropin releasing factor binding proteins. Nature 349 (1991) 423-426
37. Suda T., Iwashita M., Tozawa F., Ushiyama T., Tomori N., Sumitomo T., Nakagami Y., Demura H., and Shizume K. Characterization of corticotropin-releasing hormone binding protein in human plasma by chemical cross-linking and its binding during pregnancy. J Clin Endocrinol Metab 67 (1988) 1278-1283
38. McClennen S.J., Cortright D.N., and Seasholtz A.F. Regulation of pituitary corticotropin-releasing hormone-binding protein messenger ribonucleic acid levels by restraint stress and adrenalectomy. Endocrinology 139 (1988) 4435-4441
39. Grenback E., Bjellerup P., Wallerman E., Lundblad L., Anggard A., Ericson K., Aman K., Landry M., Schmidt W.E., Hökfelt T., and Hulting A.L. Galanin in pituitary adenomas. Regul Pept 117 (2004) 127-139
40. Tortorella C., Neri G., and Nussdorfer G.G. Galanin in the regulation of the hypothalamic-pituitary-adrenal axis. Int J Mol Med 19 (2007) 639-647